United States Patent and Trademark Office (USPTO) Public Awareness campaign strategy on the dangers of counterfeit substances or devices
Questions/Answers posted as of November 12, 2026 at 9:50 AM. THIS IS A PTAG SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY. In accordance with the Patent and Trademark Office Efficiency Act (PTOEA), 35 U.S.C. § 2(b)(4)(A), this Sources Sought Notice Request for Information) (RFI) is strictly for…
View the official notice on SAM.gov ↗
- Buyer
- US Patent and Trademark Office (Department of Commerce Pto)
- Location
- United States
- Value
- Not stated
- Deadline
- Closes 16 Nov 2026 · today
- Published
- 12 Nov 2026
- Procedure
- Sources Sought
- Codes
- NAICS 541820
- Who can bid
- Bidders need an active SAM.gov registration (Unique Entity ID); non-US companies can register but some contracts require a US presence.
- Categories
- Marketing & creative
Description
Questions/Answers posted as of November 12, 2026 at 9:50 AM. THIS IS A PTAG SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY. In accordance with the Patent and Trademark Office Efficiency Act (PTOEA), 35 U.S.C. § 2(b)(4)(A), this Sources Sought Notice Request for Information) (RFI) is strictly for market research ONLY. It is for informational and planning purposes and shall NOT be construed as a solicitation or as an obligation or commitment by the Government at this time. This RFI is being made available under NAICS 541820 - Public Relations Agencies. This effort is for campaign services to support a nationwide public awareness campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices. The USPTO is seeking information from qualified vendors regarding capabilities and relevant experience to support potential public relations services to create and execute a nationwide public awareness campaign consisting of media relations, videos, and other creative communications deliverables including a microsite and social media campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices that are falsely represented as products made or distributed by real pharmaceutical and medical device companies. Submission Instructions: Questions due: no later than October 26, 2026 at 1pm ET RFI Response Due Date: November 16, 2026 10am ET All details are located within the PDF attachment.
Source: SAM.gov Contract Opportunities (U.S. Government public data). Listing last updated 12 Nov 2026. Check the official notice for documents, clarifications and how to respond.